Evidence map›Paper›PMID 33493164›Full record

ArticlePloS one2021

Gαi1 inhibition mechanism of ATP-bound adenylyl cyclase type 5.

Daniele Narzi, Siri C van Keulen, Ursula Röthlisberger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Neuroprotective and antimalarial effects ofFrontiers in veterinary science · 2025
    Article
  2. DAT, deacylating autotransporter toxin, fromProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniele NarziInstitut des Sciences et Ingénierie Chimiques, École Polytechnicque Fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID 0000-0003-2731-6286
Siri C van KeulenInstitut des Sciences et Ingénierie Chimiques, École Polytechnicque Fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID 0000-0001-6995-8389
Ursula RöthlisbergerInstitut des Sciences et Ingénierie Chimiques, École Polytechnicque Fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID 0000-0002-1704-8591
École Polytechnique Fédérale de Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conversion of adenosine triphosphate (ATP) to the second messenger cyclic adenosine monophosphate (cAMP) is an essential reaction mechanism that takes place in eukaryotes, triggering a variety of signal transduction pathways. ATP conversion is catalyzed by the enzyme adenylyl cyclase (AC), which can be regulated by binding inhibitory, Gαi, and stimulatory, Gαs subunits. In the past twenty years, several crystal structures of AC in isolated form and complexed to Gαs subunits have been resolved. Nevertheless, the molecular basis of the inhibition mechanism of AC, induced by Gαi, is still far from being fully understood. Here, classical molecular dynamics simulations of the isolated holo AC protein type 5 and the holo binary complex AC5:Gαi have been analyzed to investigate the conformational impact of Gαi association on ATP-bound AC5. The results show that Gαi appears to inhibit the activity of AC5 by preventing the formation of a reactive ATP conformation.

Indexed as

Molecular Dynamics SimulationAdenylyl CyclasesCyclic AMPGTP-Binding Protein alpha Subunits, Gi-GoHumansMultiprotein ComplexesProtein Structure, QuaternaryAdenylyl Cyclasesadenylyl cyclase type VCyclic AMPGNAI1 protein, humanGTP-Binding Protein alpha Subunits, Gi-GoMultiprotein Complexes

Identifiers

PMID33493164
PMCPMC7833170
OpenAlexW3122458343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.